AbstractCD34+-selection of hematopoietic grafts for patients undergoing autologous hematopoietic stem cell transplantation (HSCT) is frequently used to obtain a tumor-free graft. The majority of published experience is with peripheral blood stem cell (PBSC) products; only scant information has been published on bone marrow (BM) grafts. We reviewed our experience using CD34+ selection of BM grafts in children undergoing autologous BM transplantation. After obtaining institutional approval, we performed a retrospective review of the medical records of patients who underwent autologous stem cell collection at St. Jude. From January 1, 1999, to December 31, 2003, 373 patients underwent autologous HSCT; 131 received marrow grafts, 237 received P...
AbstractBackground aimsImmunomagnetic enrichment of CD34+ hematopoietic “stem” cells (HSCs) using pa...
peer reviewedCD34+ immunomagnetic positive selection allows for CD34+ hematopoietic progenitors sepa...
The aim of this study was to evaluate which CD34(+) cell subset contained in leukapheresis products ...
AbstractCD34+-selection of hematopoietic grafts for patients undergoing autologous hematopoietic ste...
BACKGROUND: A study of CD34+ cell selection and transplantation was carried out with particular emph...
Autologous peripheral blood stem cell transplantation is currently used in the treatment of various ...
Haploidentical stem cell transplantation (SCT) is increasingly used to treat pediatric patients with...
AbstractThe CD34+ cell surface antigen is expressed on progenitor cells required for blood stem cell...
Here we review our recent experience addressing the issue of positive selection and transplantation ...
Collection of peripheral blood progenitor cells by leukapheresis is the preferred method to obtain g...
OBJECTIVE: The aim of this study was to evaluate which CD34(+) cell subset contained in leukapheresi...
Background Immunomagnetic selection of CD34+ hematopoietic progenitor cells (HPC) using CliniMACS CD...
Contamination of transplants with tumour cells may contribute to relapse after peripheral blood stem...
Background aims: Immunomagnetic enrichment of CD34+ hematopoietic “stem” cells (HSCs) using paramagn...
AbstractBone marrow (BM), granulocyte-colony stimulating factor mobilized peripheral blood stem cell...
AbstractBackground aimsImmunomagnetic enrichment of CD34+ hematopoietic “stem” cells (HSCs) using pa...
peer reviewedCD34+ immunomagnetic positive selection allows for CD34+ hematopoietic progenitors sepa...
The aim of this study was to evaluate which CD34(+) cell subset contained in leukapheresis products ...
AbstractCD34+-selection of hematopoietic grafts for patients undergoing autologous hematopoietic ste...
BACKGROUND: A study of CD34+ cell selection and transplantation was carried out with particular emph...
Autologous peripheral blood stem cell transplantation is currently used in the treatment of various ...
Haploidentical stem cell transplantation (SCT) is increasingly used to treat pediatric patients with...
AbstractThe CD34+ cell surface antigen is expressed on progenitor cells required for blood stem cell...
Here we review our recent experience addressing the issue of positive selection and transplantation ...
Collection of peripheral blood progenitor cells by leukapheresis is the preferred method to obtain g...
OBJECTIVE: The aim of this study was to evaluate which CD34(+) cell subset contained in leukapheresi...
Background Immunomagnetic selection of CD34+ hematopoietic progenitor cells (HPC) using CliniMACS CD...
Contamination of transplants with tumour cells may contribute to relapse after peripheral blood stem...
Background aims: Immunomagnetic enrichment of CD34+ hematopoietic “stem” cells (HSCs) using paramagn...
AbstractBone marrow (BM), granulocyte-colony stimulating factor mobilized peripheral blood stem cell...
AbstractBackground aimsImmunomagnetic enrichment of CD34+ hematopoietic “stem” cells (HSCs) using pa...
peer reviewedCD34+ immunomagnetic positive selection allows for CD34+ hematopoietic progenitors sepa...
The aim of this study was to evaluate which CD34(+) cell subset contained in leukapheresis products ...